Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Hanover Media Strategy Limited .
Filed returns
109
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2023 | Hanover Media Strategy Limited | Health | Ireland's readiness for the rollout of radioligand therapy (Public policy or programme) | 12 | On lobbying.ie |
| Jan–Apr 2023 | Hanover Media Strategy Limited | Transport | NCT delays (Legislation) | 4 | On lobbying.ie |
| Jan–Apr 2023 | Hanover Media Strategy Limited | Energy and Natural Resources | Activity related to joint venture between Ocean Winds and Bord na Móna, specifically Réalt na Mara Offshore Wind Farm Limited and Celtic Horizon Offshore Wind Farm Limited (Zoning or development) | 13 | On lobbying.ie |
| Jan–Apr 2023 | Hanover Media Strategy Limited | Health | Rare Disease Policy (Legislation) | 17 | On lobbying.ie |
| Sep–Dec 2022 | Hanover Media Strategy Limited | Health | Request for a meeting to discuss the landscape for innovative and precision medicines in Ireland. (Public policy or programme) | 18 | On lobbying.ie |
| Sep–Dec 2022 | Hanover Media Strategy Limited | Environment | Request for a meeting with Senator Boylan. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2022 | Hanover Media Strategy Limited | Energy and Natural Resources | Ocean Winds' offshore wind projects in Ireland (Zoning or development) | 10 | On lobbying.ie |
| Sep–Dec 2022 | Hanover Media Strategy Limited | Transport | Sharing pre-Budget submission ahead of Budget 2023 (Public policy or programme) | 20 | On lobbying.ie |
| Sep–Dec 2022 | Hanover Media Strategy Limited | Transport | To highlight the disruption caused to car rental operators as a result of NCT delays (Public policy or programme) | 8 | On lobbying.ie |
| Sep–Dec 2022 | Hanover Media Strategy Limited | Transport | The impact of vehicle supply shortages on the car rental sector (Public policy or programme) | 10 | On lobbying.ie |
| Sep–Dec 2022 | Hanover Media Strategy Limited | Health | Rare Disease Policy (Legislation) | 9 | On lobbying.ie |
| May–Aug 2022 | Hanover Media Strategy Limited | Transport | Request for a meeting with local authorities to discuss shared sustainable mobility solutions. (Matters involving public funds) | 59 | On lobbying.ie |
| May–Aug 2022 | Hanover Media Strategy Limited | Transport | Shared Pre-Budget 2023 submission to inform policy on shared transport, electrification and vehicle supply (Public policy or programme) | 29 | On lobbying.ie |
| May–Aug 2022 | Hanover Media Strategy Limited | Energy and Natural Resources | Ocean Winds' offshore wind projects in Ireland (Zoning or development) | 62 | On lobbying.ie |
| Jan–Apr 2022 | Hanover Media Strategy Limited | Health | Update on AstraZeneca sponsored roundtable outcomes held for Chronic Obstructive Pulmonary Disease (Public policy or programme) | 14 | On lobbying.ie |
| Jan–Apr 2022 | Hanover Media Strategy Limited | Communications | To share a briefing on the Communications Regulation (Enforcement) Bill 2022 (Legislation) | 13 | On lobbying.ie |
| May–Aug 2021 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 9 | On lobbying.ie |
| May–Aug 2021 | Hanover Media Strategy Limited | Transport | Building a safe, sustainable e-scooter market in Ireland (Public policy or programme) | 14 | On lobbying.ie |
| May–Aug 2021 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 9 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Finance | Consumer protection for SMEs whose loans have been sold to unregulated entities (Legislation) | 12 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 15 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 9 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Finance | The impact of Covid-19 on the car rental industry (Public policy or programme) | 20 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Health | Engagement on National Screening Advisory Committee Bill 2020 and the newborn screening programme (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 14 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Health | Provided update to select politicians on developments in Oncology therapies and barriers to access (Matters involving public funds) | 4 | On lobbying.ie |
| Sep–Dec 2020 | Hanover Media Strategy Limited | Health | Briefed select parliamentarians on potential Covid-19 vaccine (Public policy or programme) | 22 | On lobbying.ie |
| May–Aug 2020 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 10 | On lobbying.ie |
| May–Aug 2020 | Hanover Media Strategy Limited | Health | Update on potential COVID-19 Vaccine (Matters involving public funds) | 4 | On lobbying.ie |
| May–Aug 2020 | Hanover Media Strategy Limited | Transport | Cost of Motor Insurance Policies in Ireland. (Legislation) | 9 | On lobbying.ie |
| May–Aug 2020 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 16 | On lobbying.ie |
| Jan–Apr 2020 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 4 | On lobbying.ie |
| Jan–Apr 2020 | Hanover Media Strategy Limited | Transport | Cost of Motor Insurance Policies in Ireland and the role of sustainable mobility solutions in climate action solutions. (Legislation) | 6 | On lobbying.ie |
| Sep–Dec 2019 | Hanover Media Strategy Limited | Transport | Cost of Motor Insurance Policies in Ireland and the role of sustainable mobility solutions in climate action solutions. (Legislation) | 3 | On lobbying.ie |
| Sep–Dec 2019 | Hanover Media Strategy Limited | Health | The reimbursement process and pathway affecting AstraZeneca medicines & engage government on healthcare innovation (Matters involving public funds) | 7 | On lobbying.ie |
| May–Aug 2019 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 4 | On lobbying.ie |
| May–Aug 2019 | Hanover Media Strategy Limited | Health | The reimbursement process and pathway affecting AstraZeneca medicines & engage government on healthcare innovation (Matters involving public funds) | 15 | On lobbying.ie |
| Jan–Apr 2019 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 5 | On lobbying.ie |
| Jan–Apr 2019 | Hanover Media Strategy Limited | Finance | Cost of Motor Insurance Policies in Ireland (Legislation) | 27 | On lobbying.ie |
| Jan–Apr 2019 | Hanover Media Strategy Limited | Health | The reimbursement process and pathway affecting AstraZeneca medicines (Matters involving public funds) | 10 | On lobbying.ie |
| Sep–Dec 2018 | Hanover Media Strategy Limited | Finance | Finance Bill 2018 (Legislation) | 13 | On lobbying.ie |
| Sep–Dec 2018 | Hanover Media Strategy Limited | Finance | Cost of Motor Insurance Policies in Ireland (Legislation) | 21 | On lobbying.ie |
| Sep–Dec 2018 | Hanover Media Strategy Limited | Health | Creation of national policy to increase availability of Orphan Medicinal Products (Legislation) | 10 | On lobbying.ie |
| May–Aug 2018 | Hanover Media Strategy Limited | Health | Creation of national policy to increase availability of Orphan Medicinal Products (Legislation) | 13 | On lobbying.ie |
| Jan–Apr 2018 | Hanover Media Strategy Limited | Health | Reimbursement of Vimizim for Morquio A Syndrome (Matters involving public funds) | 12 | On lobbying.ie |
| Jan–Apr 2018 | Hanover Media Strategy Limited | Finance | Consumer Protection for SMEs (Legislation) | 7 | On lobbying.ie |
| Jan–Apr 2018 | Hanover Media Strategy Limited | Health | Creation of national policy to increase availability of Orphan Medicinal Products (Legislation) | 12 | On lobbying.ie |
| Sep–Dec 2017 | Hanover Media Strategy Limited | Health | Reimbursement of Vimizim for Morquio A Syndome (Matters involving public funds) | 16 | On lobbying.ie |
| Sep–Dec 2017 | Hanover Media Strategy Limited | Health | Telehealth policy in Ireland (Public policy or programme) | 5 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 52 | 47.7% | |
| Transport | 29 | 26.6% | |
| Finance | 7 | 6.4% | |
| Energy and Natural Resources | 6 | 5.5% | |
| Children and Youth Affairs | 5 | 4.6% | |
| Economic Development and Industry | 3 | 2.8% | |
| Environment | 3 | 2.8% | |
| Sports and Recreation | 3 | 2.8% | |
| Communications | 1 | 0.9% |